Smith Caldwell W MD Cumberland, RI - 02864

Smith Caldwell W MD is categorized under Internal Medicine Doctors in Cumberland, RI and active since 2010.

Smith Caldwell W MD was established in 2010, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Internal Medicine Doctors business, which does work in the B2C market, and is classified as a Internal Medicine Doctors, under code number 6211110 by the NAICS.

If you are seeking more information, feel free to contact Caldwell Smith at the company’s single location by writing to 175 Nate Whipple Highway, Cumberland, Rhode Island RI 02864 or by phoning (401) 658-0047. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Smith Caldwell W MD
Contact Person: Caldwell Smith
Address: 175 Nate Whipple Highway, Cumberland, Rhode Island 02864
Phone Number: (401) 658-0047
Website Address: retinaconsultantsri.com
Annual Revenue (USD): $100.000 to $499.999
Founded: 2010
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Internal Medicine Doctors
SIC Code: 8011
NAICS Code: 6211110
Share This Business:

Smith Caldwell W MD was started in 2010 to provide professional Internal Medicine Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.

Feel free to contact Caldwell Smith for inquiries that concern Smith Caldwell W MD by calling the company number (401) 658-0047, as your correspondence is most welcome. Additionally, the physical location of the single location of Smith Caldwell W MD can be found at the coordinates 41.97867,-71.44782 as well as the street address 175 Nate Whipple Highway in Cumberland, Rhode Island 02864.

For its online presence, you may visit Smith Caldwell W MD’s website at retinaconsultantsri.com and engage with its social media outlets through on Twitter and on Facebook.